Open surgery induces a dramatic decrease in circulating intact IGFBP-3 in patients with colorectal cancer not seen with laparoscopic surgery
- 11 November 2004
- journal article
- research article
- Published by Springer Nature in Surgical Endoscopy
- Vol. 19 (1) , 55-59
- https://doi.org/10.1007/s00464-004-8906-x
Abstract
As shown earlier by the authors via Western blot analysis, open (OS) but not laparoscopic surgery (LS) induces a qualitative decrease in plasma insulin-like growth factor-binding protein 3 (IGFBP-3) levels on postoperative day 1 (POD 1). Intact IGFBP-3 has tumor suppressive effects, but its degradation products do not. Enzyme linked immunoassay (ELISA) inevitably measures both. In this study, using a novel combined Western blot and ELISA analysis method, precise plasma levels of intact IGFBP-3 on POD2 after open and closed colorectal cancer resection (stage I-III) were determined. This study included 15 OS patients with a mean incision length of 26.7 +/- 15.5 cm and 16 LS patients with a mean incision length of 5.3 +/- 3.1 cm. Intact IGFBP-3 levels were determined via ELISA and Western blot analysis in plasma collected preoperatively and postoperatively. In the OS patients, the mean preoperative concentration of intact 43-45 kDa IGFBP-3 protein was 1920 +/- 1430 ng/ml. It decreased dramatically on POD2 to 355 +/- 545 ng/ml (p < 0.005). In the LS group, no significant difference was noted between the preoperative level (1305 +/- 807 ng/ml) and the POD2 level (922 + 714 ng/ml). Open cancer resection, unlike its minimally invasive alternative, induces a dramatic decrease in concentration of intact IGFBP-3, which may have important implications with regard to colon cancer recurrence.Keywords
This publication has 26 references indexed in Scilit:
- Depletion of Circulating Insulin-Like Growth Factor Binding Protein 3 After Open Surgery is Associated With High Interleukin-6 LevelsDiseases of the Colon & Rectum, 2004
- Matrix metalloproteinases-3, -8, -9 as markers of disease activity and joint damage progression in early rheumatoid arthritisAnnals of the Rheumatic Diseases, 2003
- Matrix Metalloproteinases as Novel Disease Markers in Takayasu ArteritisCirculation, 2003
- Insulin-like Growth Factor (IGF)-binding Protein-3 Mutants That Do Not Bind IGF-I or IGF-II Stimulate Apoptosis in Human Prostate Cancer CellsJournal of Biological Chemistry, 2002
- Effect of IL-6 on IGF Binding Protein-3: A Study in IL-6 Transgenic Mice and in Patients with Systemic Juvenile Idiopathic ArthritisEndocrinology, 2001
- INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-3 MEDIATES 1α,25-DIHYDROXYVITAMIN D 3 GROWTH INHIBITION IN THE LNCaP PROSTATE CANCER CELL LINE THROUGH P21/WAF1Journal of Urology, 2001
- High-risk colorectal adenomas and serum insulin-like growth factorsBritish Journal of Surgery, 2001
- Circulating Insulin-Like Growth Factor II and Colorectal Adenomas*Journal of Clinical Endocrinology & Metabolism, 2000
- Growth hormone-dependent insulin-like growth factor (IGF) binding protein from human plasma differs from other human igf binding proteinsBiochemical and Biophysical Research Communications, 1986
- Plasma Levels of Insulin-Like Growth Factor-1 and Binding Protein-3, and Their Association With Bladder Cancer RiskPublished by Wolters Kluwer Health